2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 96%, 1g

4-Fluoro-2-methylbenzoic Acid>98.0%(GC)(T)25g

Ethyl 2,5-dibromobenzoate, 25g

C-(3-Adamantan-1-yl-[1,2,4]oxadiazol-5-yl)-methylamine; hydrochloride, 95.0%, 1g

(S)-Methyl 2,2-dimethyl-1,3-dioxolane-4-carboxylate, 95.0%, 1g

4-Hydroxy-6-(trifluoromethoxy)-2-(trifluoromethyl)quinoline, 95.0%, 10g

2,4-Dichloro-6-methoxy-1,5-naphthyridine, 97%, 1g

1-(4-Fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one hydrochloride, 95.0%, 1g

6-Bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine, 95.0%, 5g

3-(1-(2-Hydroxyethyl)piperidin-4-yl)propan-1-ol, 95+%, 25g

(R)-N-(4-(3-AMINOPIPERIDIN-1-YL)-5-BROMO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)CYCLOPROPANECARBOXAMIDE, 95%, 25mg

Schwefelsäure, 4 mol/l - 8 N Maßlösung, 1 l, kunststoffverpackung.

n-Cyclobutyl-4-ethylaniline, 98%, 1g